华大智造：拟将部分募投项目结项，15768.23万元节余资金拟用于补充流动资金

Core Viewpoint - The company, BGI Genomics, announced the conclusion of the "BGI Genomics R&D Center Project" and the allocation of surplus funds for enhancing its liquidity [1] Group 1: Project Conclusion - The second board meeting of the company will be held on January 31, 2026, to review the conclusion of the R&D center project [1] - The project has reached the predetermined usable status, allowing for its formal conclusion [1] Group 2: Financial Details - The surplus funds amount to 157.68 million yuan, which includes interest income and net financial gains [1] - The company plans to use the surplus funds to permanently supplement its working capital [1] - Following the transfer of surplus funds, the company will close related fundraising accounts at two branches of China Merchants Bank [1]